|
Volumn 255, Issue SUPPL. 5, 2008, Pages 39-47
|
Lewy body dementia and Parkinson's disease with dementia
|
Author keywords
synuclein; Cholinesterase inhibitors; Dementia; Dementia with Lewy bodies; Parkinson's disease
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ANTIPARKINSON AGENT;
CHOLINESTERASE INHIBITOR;
CLOZAPINE;
DONEPEZIL;
DOPAMINE RECEPTOR STIMULATING AGENT;
GALANTAMINE;
LEVODOPA;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
RIVASTIGMINE;
SELEGILINE;
ANXIETY;
AUTONOMIC DYSFUNCTION;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONFERENCE PAPER;
CONSCIOUSNESS;
CONSCIOUSNESS DISORDER;
DEMENTIA;
DEPRESSION;
DISEASE ASSOCIATION;
DISEASE COURSE;
EXTRAPYRAMIDAL SYMPTOM;
FAMILY;
HALLUCINATION;
HALLUCINOSIS;
HUMAN;
INCIDENCE;
LEWY BODY;
NEUROLEPTIC MALIGNANT SYNDROME;
NEUROPSYCHOLOGY;
NEUROTRANSMISSION;
PARKINSON DISEASE;
PARKINSONISM;
PREVALENCE;
PRIORITY JOURNAL;
PSYCHIATRY;
PSYCHOSIS;
SIDE EFFECT;
SLEEP;
SLEEP DISORDER;
COGNITION DISORDERS;
DEMENTIA;
HUMANS;
LEWY BODY DISEASE;
NEUROPSYCHOLOGY;
PARKINSON DISEASE;
SLEEP;
|
EID: 51749089565
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-008-5007-0 Document Type: Conference Paper |
Times cited : (52)
|
References (41)
|